BIVI BIOVIE INC

-

BIOVIE INC Reported Earnings

Wednesday, August 12, 2026 · 12:00 AM ET

BIOVIE INC (BIVI) reported a loss of $0.70 per share on revenue of $0.00 million for the . .

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.70)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth